Multiplexing is critical in the burgeoning field of point-of-care testing. Increasing the number of simultaneous assays helps to identify the right biomarker, and thus reduces the cost and time it takes to quell any potential outbreak. With that, ALiA BioTech says it is ready to deploy a next-generation rapid diagnostic platform that can conduct multiplex testing in a single biochip within 15 minutes.

“It becomes very personal now,” says Kelvin Chiu, CEO of ALiA BioTech. “Next time we sneeze or cough, we could be catching Covid-19, influenza, respiratory syncytial virus, or Streptococcus pneumoniae. A single test on our platform gives the fast track and accurate answer.”

Lab-on-Chip Platform

ALiA’s lab-on-chip platform is a patented point-of-care testing that delivers up to 30 results from a single drop of body fluid, whether that be blood, serum, swab, or urine. Having completed research and development of its proprietary microfluidic and microarray technologies, ALiA says it is ready to scale up the manufacturing of multiplex products for different disease panels. The company’s pipeline will also direct point-of-care testing towards veterinary health and agri-food surveillance within the same platform.

ALiA analyzer and its biochip panels for respiratory infection and tropical fever have obtained Europe’s CE marks, with the accredited ISO 13485 medical device quality management system.

The biotech firm is securing regulatory approval in other jurisdictions, including the United States, mainland China, and Southeast Asia. The company anticipates global strategic partnerships in developing biochips for different disease panels and aims to deepen ties around product development and commercialization. It also welcomes strategic partnerships to establish advanced manufacturing in the U.S., European Union, and Asia-Pacific.

“Over the next five to 10 years, we shall develop more multiplex diseases panels and complete clinical trials and regulatory approval processes so that we can introduce more real-time rapid diagnostic panels that are critical to rescuing lives,” Chiu says.